Plasma uric acid levels in women with cervical intraepithelial neoplasia

Nutrition and Cancer

Volumn 51, Issue 1, 2005, Pages 25-31

  Basu, Jayasri ^a   Mikhail, Magdy S ^b   Ahn, Chul W ^c   Furguiele, Joseph ^a   Ho, Gloria Y ^a   Burk, Robert D ^a   Palan, Prabhudas R ^b   Romney, Seymour L ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b BRONX LEBANON HOSPITAL CENTER   (United States)

^c UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; URIC ACID;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MULTIPLE REGRESSION; URIC ACID BLOOD LEVEL; UTERINE CERVIX CARCINOMA IN SITU; WART VIRUS;

ADULT; AGED; ANTIOXIDANTS; CERVICAL INTRAEPITHELIAL NEOPLASIA; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CREATININE; CROSS-SECTIONAL STUDIES; DNA PROBES, HPV; FEMALE; HUMANS; LOGISTIC MODELS; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; SEVERITY OF ILLNESS INDEX; URIC ACID; UTERINE CERVICAL NEOPLASMS;

HUMAN PAPILLOMAVIRUS;

EID: 14944360618     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1207/s15327914nc5101_4     Document Type: Article

References (33)

1. Trush MA and Kensler TW; An overview of the relationship between oxidative stress and chemical carcinogenesis. Free Radic Biol Med 10, 201-209, 1991.
2. Byers T and Perry G: Dietary carotenes, vitamin C and vitamin E as protective antioxidants in human cancers. Annu Rev Nutr 12, 139-159, 1992.
3. Wassertheil-Smoller S, Romney SL, Wylie-Rosett J, Slagle S, Miller G, et al.: Dietary vitamin C and uterine cervical dysplasia. Am J Epidemiol 114, 714-724, 1981.
4. Basu J, Palan PR, Vermund SH, Goldberg GL, Burk RD, et al.: Plasma ascorbic acid and β-carotene levels in women evaluated for HPV infection, smoking and cervix dysplasia. Cancer Detect Prev 15, 165-70, 1991.
5. Ho GY, Palan PR, Basu J, Romney SL, Kadish AS, et al.: Viral characteristics of human papillomavirus infection and antioxidant levels as risk factors for cervical dysplasia. Int J Cancer 78, 594-599, 1998.
6. Sedjo RL, Roe DJ, Abrahamsen M, Harris RB, Craft N, et al.: Vitamin A, carotenoids and risk of persistent oncogenic human papillomavirus infection. Cancer Epidemiol Biomarkers Prev 11, 876-884, 2002.
7. Schiff MA, Patterson RE, Baumgartner RN, Masuk M, vanAsselt-King L, et al. Serum carotenoids and risk factors of cervical intraepithelial neoplasia in Southwestern American Indian women. Cancer Epidemiol Biomarkers Prev 10, 1219-1222, 2001.
8. Mackerras D, Irwig L, Simpson JM, Weisberg E, Cardona M, et al.: Randomized double-blind trial of β- carotene and vitamin C in women with minor cervical abnormalities. Brit J Cancer 79, 1448-1453, 1999.
9. Yeo AS, Schiff MA, Monotoya G, Masuk M, vanAsselt-King L, et al.: Serum micronutrients and cervical dysplasia in Southwestern American Indian women. Nutr Cancer 38, 141-150, 2000.
10. Postichman N and Brinton LA: Nutrition and cervical neoplasia. Cancer Causes Control 7, 113-126, 1996.
11. Becker BF, Reinholz N, Leipert B, Raschke P, Permanetter B, et al.: Role of uric acid as an endogenous radical scavenger and antioxidant. Chest 100, 176S-181S, 1991.
12. Buettner GR: The pecking order of free radicals and antioxidants: lipid peroxidation, α- tocopherol, and ascorbate. Arch Biochem Biophys 300, 535-543, 1993.
13. Kaur H and Halliwell B: Action of biological relevant oxidizing species upon uric acid; identification of uric acid oxidation products. Chem Biol Interaction 73, 235-247, 1990.
14. Burgaz S, Torun M, Yardin S, Sargin H, Orman MN, et al.: Serum carotenoids and uric acid levels in relation to cancer. J Clin Pharm Ther 21, 331-336, 1996.
15. Bozkir A, Simsek B, Gungort A, and Torun M: Ascorbic acid and uric acid levels in lung cancer patients. J Clin Pharm Ther 24, 43-47, 1999.
16. Fabiny DL and Ertingshausen G: Automated reaction rate method for determination of serum creatinine with the CentrifiChem. Clin Chem 17, 697-700, 1971.
17. Hsing AW, Burk RD, Liaw KL, Chen CJ, Zhang T, et al.: Interlaboratory agreement in a polymerase chain reaction-based human papillomavirus DNA assay. Cancer Epidemiol Biomarkers Prev 5, 483-484, 1996.
18. Moscicki AB, Hills N, Shiboski S, Powell K, Jay N, et al.: Risks for incident human papillomavirus infection and low grade squamous intraepithelial lesion development in young females. JAMA 285, 2995-3002, 2001.
19. Syrjanen K, Kataja V, Yliskoski M, Chang F, Syrjanen S, et al.: Natural history of cervical human papillomavirus lesions does not substantiate the biologic relevance of the Bethesda System. Obstet Gynecol 79, 675-682, 1992.
20. Jastreboff AM and Cymet T: Role of the human papillomavirus in the development of cervical intraepithelial neoplasia and malignancy. Postgrad Med J 78, 225-228, 2002.
21. Schiffman MH and Castle P: Epidemiologic studies of a necessary causal risk factor: human papillomavirus infection and cervical neoplasia. J Natl Cancer Inst 95, E2, 2003.
22. Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, et al.: Prevalence of human papillomavirus in cervical cancer: A worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst 87, 796-802, 1995.
23. Moreno V, Munoz N, Bosch FX, De Sanjose S, Gonzales, LC, et al.: Risk factors for progression of cervical intraepithelial neoplasm grade III to invasive cervical cancer. Cancer Epidemiol Biomarkers Prev 4, 459-467, 1995.
24. Ho GY, Burk RD, Klein S, Kadish AS, Chang CJ, et al.: Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst 87, 1365-1371, 1995.
25. de Vet HC, Sturmans F, and Knipschild PG: The role of cigarette smoking in the etiology of cervical dysplasia. Epidemiology S, 631-633, 1994.
26. Kjellberg L, Hallmans G, Ahren AM, Johansson R, Bergman F, et al.: Smoking, diet, pregnancy and oral contraceptive use as risk factors for cervical intra-epithelial neoplasia in relation to human papillomavirus infection. Br J Cancer 82, 1332-1338, 2000.
27. Munoz N, Bosch FX, de Sanjose S, and Shah KV: The role of HPV in the etiology of cervical cancer. Mutat Res 305, 293-301, 1994.
28. Yamamoto T, Yokoyama H, Moriwaki Y, Takahashi S, Suda M, et al.: The effect of completely purine-free diet of low sodium content on purine intermediates and end-product. Eur J Clin Nutr 44, 659-664, 1990.
29. Ames BN, Cathcart R, Schwiers E, and Hochstein P: Uric acid provides an antioxidant defense in human against oxidant- and radical-caused by aging and cancer: a hypothesis. Proc Natl Acad Sci USA 78, 6858-6862, 1981.
30. Abiaka C, Al-Awadi F, Gulshan S, Al-Sayer H, Behbehani A, et al.: Plasma concentrations of α-tocopherol and urate in patients with different types of cancer. J Clin Pharm Ther 26, 265-270, 2001.
31. Sevanian A, Davies KJ, and Hochstein P: Serum urate as an antioxidant for ascorbic acid. Am J Clin Nutr 54, 1129S-1134S, 1991.
32. Shi Y, Evans JE, and Rock KL: Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 425, 516-521, 2003.
33. Cerutti PA and Trump BF: Inflammation and oxidative stress in carcinogenesis. Cancer Cells 3, 1-7, 1991.